Studies have shown that overexpression or activation of MET in NSCLC is linked to an increase in PD-L1 expression and the upregulation of immunosuppressive genes such as PDCD1LG2 and SOCS1 [186,187]. This evidence concerns the gene MET and non-small cell lung carcinoma.